Stock Price
373.05
Daily Change
3.50 0.95%
Monthly
7.58%
Yearly
-37.79%
Q1 Forecast
351.07

Novo Nordisk reported DKK512.29B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Bausch Health Companies USD 26.82B 442M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novo Nordisk DKK 512.29B 30.14B Sep/2025
Novo Nordisk DKK 76.18B 412.98B Jun/2025
Pacira USD 1.3B 239.68M Sep/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025